0001209191-17-057532.txt : 20171019
0001209191-17-057532.hdr.sgml : 20171019
20171019213302
ACCESSION NUMBER: 0001209191-17-057532
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171017
FILED AS OF DATE: 20171019
DATE AS OF CHANGE: 20171019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crowley John F
CENTRAL INDEX KEY: 0001400973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 171145846
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-17
0
0001178879
AMICUS THERAPEUTICS INC
FOLD
0001400973
Crowley John F
C/O AMICUS THERAPEUTICS, INC.
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
1
1
0
0
Chairman & CEO
Common Stock
2017-10-17
4
M
0
52722
14.75
A
380723
D
Common Stock
2017-10-17
4
S
0
52722
14.75
D
328001
D
Common Stock
2017-10-18
4
M
0
19013
14.7554
A
347014
D
Common Stock
2017-10-18
4
S
0
19013
14.7554
D
328001
D
Common Stock
64895
I
By Trust
Stock Options (right to buy)
3.53
2017-10-17
4
M
0
52722
0.00
D
2017-01-28
2023-01-28
Common Stock
52722
39521
D
Stock Options (right to buy)
3.53
2017-10-18
4
M
0
19013
0.00
D
2017-01-28
2023-01-28
Common Stock
19013
20508
D
The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.75 to $14.79. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.75 to $14.79. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares were sold to fund the "Megan K. Crowley 2016 Special Needs Trust", a trust for the benefit of Mr. Crowley's child, with the balance of the proceeds used for general estate planning purposes. The total shares sold represented less than 2% of Mr. Crowley's holdings of securities of the company.
/s/ John F. Crowley
2017-10-19